News
09-04-2018, 11:16 AM
A large genomic analysis has linked certain DNA mutations to a high risk of relapse in estrogen receptor positive breast cancer, while other mutations were associated with better outcomes, according to researchers from Washington University School of Medicine in St. Louis, the Baylor College of Medicine and the University of British Columbia.
More... (https://www.news-medical.net/news/20180904/Study-finds-new-clues-to-understand-relapse-in-breast-cancer.aspx)
More... (https://www.news-medical.net/news/20180904/Study-finds-new-clues-to-understand-relapse-in-breast-cancer.aspx)